SCHEMBL996690

SCHEMBL996690

C[CH]CCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8366321 0.97
SCHEMBL8326504 0.97 DNM1 (0.50)
SCHEMBL995557 0.97 DNM1 (0.50)
SCHEMBL1403811 0.97
SCHEMBL3098989 0.90
SCHEMBL84155 0.82
SCHEMBL9668013 0.78 TSHR (0.35)
SCHEMBL7870810 0.78
SCHEMBL9421489 0.78 TSHR (0.35)
SCHEMBL9670647 0.78 TSHR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980003-A Fatty acid conjugates of nucleic acids 嘉德治疗有限责任公司 2024-05-03 CN disclosed
CN-111971269-B Reaction of glycolaldehyde 塔明克私人有限公司 2024-02-13 CN disclosed
CN-117487811-A Compositions and methods for treating complications and diseases associated with von willebrand factor 邦德治疗有限公司 2024-02-02 CN disclosed
US-20240002861-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS BAND THERAPEUTICS, LLC (US) 2024-01-04 US disclosed
CN-110520128-B Compositions and methods for treating complications and diseases associated with von Willebrand Factor 邦德治疗有限公司 2023-11-14 CN disclosed
CN-116723863-A Compositions and methods for treating hemorrhagic disorders 邦德治疗有限公司 2023-09-08 CN disclosed
WO-2020132582-A1 STING AGONISTS AND USES THEREOF NIMBUS TITAN, INC. (US) 2020-06-25 WO disclosed
CN-106257335-B Electrophotographic member, process cartridge, and electrophotographic apparatus 佳能株式会社 2020-01-24 CN disclosed
CN-110023499-A Tumor necrosis factor-alpha (TNF-α) combines aptamers and its therapeutical uses 拜欧亿思有限公司 2019-07-16 CN disclosed
WO-2018145086-A1 MULTIMERIC OLIGONUCLEOTIDES HAVING DECREASED KIDNEY CLEARANCE MPEG LA, LLC (US) 2018-08-09 WO disclosed
WO-1999005319-A2 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE, INC. (US) 1999-02-04 WO disclosed
CN-1147267-A Polymerizable composition and application thereof CIBA GEIGY AG (CH) 1997-04-09 CN disclosed
US-5470834-A Metalloproteinase enzyme inhibitors for arthritis, rheumatism and cancers FLORIDA STATE UNIVERSITY (US) 1995-11-28 US disclosed
WO-1994013325-A9 PEPTIDE LINKERS FOR IMPROVED OLIGONUCLEOTIDE DELIVERY 1994-08-18 WO disclosed
WO-1994013325-A2 PEPTIDE LINKERS FOR IMPROVED OLIGONUCLEOTIDE DELIVERY MICROPROBE CORPORATION (US) 1994-06-23 WO disclosed
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 EP disclosed
EP-0431080-A4 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY 1992-10-21 EP disclosed
EP-0431080-A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY AUSTRALIAN COMMERCIAL RESEARCH &amp; DEVELOPMENT LIMITED (AU) 1991-06-12 EP disclosed
WO-1990002141-A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) 1990-03-08 WO disclosed
US-4206117-A Pyridinyl aminoalkyl ethers BASF AKTIENGESELLSCHAFT (DE) 1980-06-03 US disclosed